Welcoming you for any type of article submission for the upcoming issue on/before February 26, 2021.

Volume 5 Issue 12 - 2020
Cardiometabolic Diseases, Risk Stratification, and Management
Gundu HR Rao*
Emeritus Professor, Laboratory Medicine and Pathology, Director, Thrombosis Research, Lillehei Heart Institute, University of Minnesota, USA
*Corresponding Author: Gundu HR Rao, Emeritus Professor, Laboratory Medicine and Pathology, Director, Thrombosis Research, Lillehei Heart Institute, University of Minnesota, USA.
Received: October 26, 2020; Published: November 07, 2020

Cardiometabolic diseases such as hypertension, excess weight, obesity, type-2 diabetes, and vascular diseases have reached epidemic proportions worldwide [1-8]. Globally, an estimated 26% of the population of the World’s population (972 million) has hypertension. To achieve the global target to reduce the prevalence of hypertension by 25% by 2025, World Health Organization (WHO) and the United States Centers for Disease Control (CDC) and Prevention have launched the Global Hearts Initiative. With its technical package-HEARTS (manage cardiovascular diseases), MPOWER (control tobacco), Active (increased physical activity), SHAKE (reduce salt consumption) and REPLACE (eliminate trans-fat), the initiatives aim to improve heart health worldwide. Despite growing recognition of the problem, the obesity epidemic continues in the US at alarming rate. The prevalence of obesity currently is 40% among young adults aged 20 - 40 years, 45% among middle-aged adults aged 40 to 60 years, and 43% among adults aged 60 and older. Type-2 diabetes has become the biggest epidemic of this century worldwide. China and India lead the world, in terms of number of diabetic individuals. What really is baffling is the fact, that there are more prediabetics than diabetics. For instance, in the USA diabetic population is about 30 million. Whereas, according to the CDC, there are more than 100 million pre-diabetics. Diabetic population in China and India are close to 116 million and 80 million respectively. Worldwide prevalence of diabetes is estimated at 463 million and if we add pre-diabetics to this number, it would exceed a billion individuals. Cardiovascular diseases are the most common noncommunicable diseases globally, responsible for an estimated 18 million deaths in 2017, of which more than three quarters, were in low-income and middle-income countries.


  1. Hu C and Jia W. “Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medicine”. Diabetes1 (2018): 3-11.
  2. Shen Xi., et al. “The Diabetic Epidemic in China: An Integrated Review of National Surveys”. Endocrine Practice 9 (2016): 1119-1129.
  3. Saeedi P., et al. “Global and regional diabetes prevalence estimates for 2019 and projections of 1030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”. Lancet107843 (2019).
  4. Mills KT., et al. “Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-based Studies from 90 Countries”. Circulation6 (2016): 441-450.
  5. NCD Risk Factor Collaboration (NCD-RisC): Worldwide trends in body-mass index. Underweight, overweight, and obesity from 1975-2016: a pooled analysis of 2416 population-based measurements in 128.9 million children, adolescents and adults 390.10113 (2017): P2627-2642.
  6. Song P., et al. “Global and regional prevalence, burden and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modeling study”. Lancet Global Health5 (2020): E721.E729.
  7. Roth GA., et al. “Global, regional, and national age-sex specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the 8). Global Burden of Disease Study 2017”. Lancet 392 (2018): 1736-1788.
  8. The WHO CVD Risk Chart Working Group. “World Health Organization Cardiovascular Disease Risk Charts: Revised Models to Estimate Risk in 21 Global Regions”. Lancet 7 (2019): E1332-E1345.
  9. Yusuf S., et al. “Effect of potentially modifiable risk factors associated with myocardial infraction in 52 countries (the INTERHEART study): a case-control study”. Lancet 364 (2004): 937-952.
  10. Di Cesare M., et al. “The contributions of risk factor trends to cardiometabolic mortality declines in 26 industrialized countries”. International Journal of Epidemiology 3 (2013): 838-848.
  11. Khera AV., et al. “Genetic risk, adherence to a healthy lifestyle, and coronary artery disease”. The New England Journal of Medicine 375 (2016): 2349-2358.
  12. O’Donnell MJ., et al. “Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case control-study”. Lancet 388 (2016): 761-765.
  13. Lopez-Jaramillo P., et al. “Epidemic of cardiometabolic diseases: A Latin American Point of View”. Therapeutic Advances in Cardiovascular Disease 2 (2011): 119-131.
  14. Gu D., et al. “Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (Inter Asia)”. Circulation 112 (2005): 658-665.
  15. Rao GHR. “Coronavirus Disease (COVID-19) and Acute Vascular Events: Editorial”. Clinical and Applied Thrombosis/Hemostasis (2020): 26.
  16. Rao GHR. “Coronavirus (COVID-19), Comorbidities, and Acute Vascular Events; Guest Editorial”. EC Clinical Case Reports6 (2020): 87-91.
  17. Rao GHR. “Coronavirus Disease (Covid-19), Comorbidities, and Clinical Manifestations. Guest Editorial”. EC Diabetes and Metabolic Research 6 (2020): 27-33.
  18. Rao GHR. “Excess weight, Obesity, Diabetes and Coronavirus Disease”. Archives of Diabetes and Obesity 1 (2020).
  19. Chow JH., et al. “Aspirin us is associated with decreased mechanical ventilation, ICU admission and in-hospital mortality of hospitalized patients with COVID-10”. Journal of Anesthesia and Analgesia (2020).
  20. Cohn JN., et al. “Screening for early detection of cardiovascular disease in asymptomatic individuals”. American Heart Journal 4 (2003): 679-685.
  21. Rao GHR., et al. “Clinical Complications of Type-2 Diabetes Mellitus in South Asians and Chinese Populations: An Overview”. Diabetes and Metabolism 5 (2014): 420.
  22. Rao GHR. “Risk Prediction, Assessment, and Management of Type-2 Diabetes”. EC Endocrinology and Metabolic Research 1 (2018): 30-41.
  23. Malmefeldt E and Rao GHR: “Changing Concepts of Healthcare: Physical Activity, Fitness and Wellness”. EC Endocrinology and Metabolic Research 6 (2019): 238-250.
  24. Cohen JT., et al. “Does Preventive Care Save Money? Health Economics and the Presidential Candidates”. The New England Journal of Medicine 358 (2008): 661-663.
  25. Cutler DM and Summers LH. “The COVID-19 Pandemic and the $16 trillion virus”. The Journal of the American Medical Association 15 (2020): 1495-1496.
Citation: Gundu HR Rao. “Cardiometabolic Diseases, Risk Stratification, and Management”. EC Endocrinology and Metabolic Research 5.12 (2020): 01-04.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 23, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.